{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:48:08Z","timestamp":1761155288417},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T00:00:00Z","timestamp":1253059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s12017-009-8089-7","type":"journal-article","created":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T07:55:56Z","timestamp":1253001356000},"page":"86-97","source":"Crossref","is-referenced-by-count":23,"title":["Dietary Supplementation with S-Adenosyl Methionine Delays the Onset of Motor Neuron Pathology in a Murine Model of Amyotrophic Lateral Sclerosis"],"prefix":"10.1007","volume":"12","author":[{"given":"James","family":"Suchy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangmook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambar","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,16]]},"reference":[{"key":"8089_CR1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/14660820310011278","volume":"4","author":"J Agar","year":"2003","unstructured":"Agar, J., & Durham, H. (2003). Relevance of oxidative injury in the pathogenesis of motor neuron diseases. Amyotroph Lateral Scler Other Motor Neuron Disord, 4, 232\u2013242.","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"8089_CR2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.brainresrev.2004.05.003","volume":"47","author":"LH Barbeito","year":"2004","unstructured":"Barbeito, L. H., Pehar, M., Cassina, P., Vargas, M. R., Peluffo, H., Viera, L., et al. (2004). A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Research Brain Research Reviews, 47, 263\u2013274.","journal-title":"Brain Research Brain Research Reviews"},{"key":"8089_CR3","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bbadis.2006.03.008","volume":"1762","author":"SC Barber","year":"2006","unstructured":"Barber, S. C., Mead, R. J., & Shaw, P. J. (2006). Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target. Biochimica et Biophysica Acta, 1762, 1051\u20131067.","journal-title":"Biochimica et Biophysica Acta"},{"key":"8089_CR4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/exnr.1998.6984","volume":"155","author":"P Barneoud","year":"1999","unstructured":"Barneoud, P., & Curet, O. (1999). Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis. Experimental Neurology, 155, 243\u2013251.","journal-title":"Experimental Neurology"},{"key":"8089_CR5","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1097\/00001756-199709080-00012","volume":"8","author":"P Barneoud","year":"1997","unstructured":"Barneoud, P., Lolivier, J., Sanger, D. J., Scatton, B., & Moser, P. (1997). Quantitative motor assessment in FALS mice: A longitudinal study. NeuroReport, 8, 2861\u20132865.","journal-title":"NeuroReport"},{"key":"8089_CR6","doi-asserted-by":"crossref","first-page":"1151S","DOI":"10.1093\/ajcn\/76.5.1151S","volume":"76","author":"T Bottiglieri","year":"2002","unstructured":"Bottiglieri, T. (2002). S-Adenosyl-L-methionine (SAMe): From the bench to the bedside\u2013molecular basis of a pleiotropic molecule. American Journal of Clinical Nutrition, 76, 1151S\u20131157S.","journal-title":"American Journal of Clinical Nutrition"},{"key":"8089_CR7","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/jnnp.53.12.1096","volume":"53","author":"T Bottiglieri","year":"1990","unstructured":"Bottiglieri, T., Godfrey, P., Flynn, T., Carney, M. W., Toone, B. K., & Reynolds, E. H. (1990). Cerebrospinal fluid S-adenosylmethionine in depression and dementia: Effects of treatment with parenteral and oral S-adenosylmethionine. Journal of Neurology, Neurosurgery and Psychiatry, 53, 1096\u20131098.","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"8089_CR8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1146\/annurev.neuro.27.070203.144244","volume":"27","author":"LI Bruijn","year":"2004","unstructured":"Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004). Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annual Review of Neuroscience, 27, 723\u2013749.","journal-title":"Annual Review of Neuroscience"},{"key":"8089_CR9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1533317508325093","volume":"23","author":"A Chan","year":"2008","unstructured":"Chan, A., Paskavitz, J., Remington, R., Rasmussen, S., & Shea, T. B. (2008a). Efficacy of a vitamin\/nutriceutical formulation for early-stage Alzheimer\u2019s disease: A 1-year, open-label pilot study with an 16-month caregiver extension. American Journal of Alzheimer\u2019s Disease and Other Dementias, 23, 571\u2013585.","journal-title":"American Journal of Alzheimer\u2019s Disease and Other Dementias"},{"key":"8089_CR10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12017-007-8005-y","volume":"9","author":"A Chan","year":"2007","unstructured":"Chan, A., & Shea, T. B. (2007). Effects of dietary supplementation with N-acetyl cysteine, acetyl-L-carnitine and S-adenosyl methionine on cognitive performance and aggression in normal mice and mice expressing human ApoE4. Neuromolecular Medicine, 9, 264\u2013269.","journal-title":"Neuromolecular Medicine"},{"key":"8089_CR11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF02982630","volume":"12","author":"A Chan","year":"2008","unstructured":"Chan, A., Tchantchou, F., Graves, V., Rozen, R., & Shea, T. B. (2008b). Dietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression: Critical role of S-adenosyl methionine. The Journal of Nutrition, Health and Aging, 12, 252\u2013261.","journal-title":"The Journal of Nutrition, Health and Aging"},{"key":"8089_CR12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neuroscience.2006.09.064","volume":"144","author":"L Chi","year":"2007","unstructured":"Chi, L., Ke, Y., Luo, C., Gozal, D., & Liu, R. (2007). Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience, 144, 991\u20131003.","journal-title":"Neuroscience"},{"key":"8089_CR13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1096\/fasebj.10.4.8647346","volume":"10","author":"PK Chiang","year":"1996","unstructured":"Chiang, P. K., Gordon, R. K., Tal, J., Zeng, G. C., Doctor, B. P., Pardhasaradhi, K., et al. (1996). S-Adenosylmethionine and methylation. FASEB Journal, 10, 471\u2013480.","journal-title":"FASEB Journal"},{"key":"8089_CR14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/ars.2007.1760","volume":"10","author":"M Cozzolino","year":"2008","unstructured":"Cozzolino, M., Ferri, A., & Carri, M. T. (2008). Amyotrophic lateral sclerosis: From current developments in the laboratory to clinical implications. Antioxidants and Redox Signaling, 10, 405\u2013443.","journal-title":"Antioxidants and Redox Signaling"},{"key":"8089_CR15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000085063","volume":"1","author":"L Dupuis","year":"2004","unstructured":"Dupuis, L., Gonzalez de Aguilar, J. L., Oudart, H., de Tapia, M., Barbeito, L., & Loeffler, J. P. (2004). Mitochondria in amyotrophic lateral sclerosis: A trigger and a target. Neuro-Degenerative Diseases, 1, 245\u2013254.","journal-title":"Neuro-Degenerative Diseases"},{"key":"8089_CR16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/exnr.1997.6763","volume":"150","author":"BE Dwyer","year":"1998","unstructured":"Dwyer, B. E., Lu, S. Y., & Nishimura, R. N. (1998). Heme oxygenase in the experimental ALS mouse. Experimental Neurology, 150, 206\u2013212.","journal-title":"Experimental Neurology"},{"key":"8089_CR17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbrc.2008.02.009","volume":"368","author":"K Erdmann","year":"2008","unstructured":"Erdmann, K., Cheung, B. W., Immenschuh, S., & Schroder, H. (2008). Heme oxygenase-1 is a novel target and antioxidant mediator of S-adenosylmethionine. Biochemical and Biophysical Research Communications, 368, 937\u2013941.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"8089_CR18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/1531-8249(200010)48:4<686::AID-ANA21>3.0.CO;2-H","volume":"48","author":"E Esposito","year":"2000","unstructured":"Esposito, E., Rossi, C., Amodio, R., Di Castelnuovo, A., Bendotti, C., Rotondo, T., et al. (2000). Lyophilized red wine administration prolongs survival in an animal model of amyotrophic lateral sclerosis. Annals of Neurology, 48, 686\u2013687.","journal-title":"Annals of Neurology"},{"key":"8089_CR19","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.freeradbiomed.2004.07.008","volume":"37","author":"M Exner","year":"2004","unstructured":"Exner, M., Minar, E., Wagner, O., & Schillinger, M. (2004). The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radical Biology and Medicine, 37, 1097\u20131104.","journal-title":"Free Radical Biology and Medicine"},{"key":"8089_CR20","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1073\/pnas.0708022105","volume":"105","author":"F Fornai","year":"2008","unstructured":"Fornai, F., Longone, P., Cafaro, L., Kastsiuchenka, O., Ferrucci, M., Manca, M. L., et al. (2008). Lithium delays progression of amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 105, 2052\u20132057.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"8089_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1022476724381","volume":"23","author":"K Fujita","year":"1998","unstructured":"Fujita, K., Kato, T., Yamauchi, M., Ando, M., Honda, M., & Nagata, Y. (1998). Increases in fragmented glial fibrillary acidic protein levels in the spinal cords of patients with amyotrophic lateral sclerosis. Neurochemical Research, 23, 169\u2013174.","journal-title":"Neurochemical Research"},{"key":"8089_CR22","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1471-4159.1982.tb08702.x","volume":"38","author":"A Gharib","year":"1982","unstructured":"Gharib, A., Sarda, N., Chabannes, B., Cronenberger, L., & Pacheco, H. (1982). The regional concentrations of S-adenosyl-L-methionine, S-adenosyl-L-homocysteine, and adenosine in rat brain. Journal of Neurochemistry, 38, 810\u2013815.","journal-title":"Journal of Neurochemistry"},{"key":"8089_CR23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.expneurol.2006.11.002","volume":"204","author":"JF Grunfeld","year":"2007","unstructured":"Grunfeld, J. F., Barhum, Y., Blondheim, N., Rabey, J. M., Melamed, E., & Offen, D. (2007). Erythropoietin delays disease onset in an amyotrophic lateral sclerosis model. Experimental Neurology, 204, 260\u2013263.","journal-title":"Experimental Neurology"},{"key":"8089_CR24","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1093\/hmg\/ddg267","volume":"12","author":"H Guo","year":"2003","unstructured":"Guo, H., Lai, L., Butchbach, M. E., Stockinger, M. P., Shan, X., Bishop, G. A., et al. (2003). Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Human Molecular Genetics, 12, 2519\u20132532.","journal-title":"Human Molecular Genetics"},{"key":"8089_CR25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410390203","volume":"39","author":"ME Gurney","year":"1996","unstructured":"Gurney, M. E., Cutting, F. B., Zhai, P., Doble, A., Taylor, C. P., Andrus, P. K., et al. (1996). Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Annals of Neurology, 39, 147\u2013157.","journal-title":"Annals of Neurology"},{"key":"8089_CR26","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., et al. (1994). Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science, 264, 1772\u20131775.","journal-title":"Science"},{"key":"8089_CR27","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1089\/ars.2006.8.2075","volume":"8","author":"K Hensley","year":"2006","unstructured":"Hensley, K., Mhatre, M., Mou, S., Pye, Q. N., Stewart, C., West, M., et al. (2006). On the relation of oxidative stress to neuroinflammation: Lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxidants and Redox Signaling, 8, 2075\u20132087.","journal-title":"Antioxidants and Redox Signaling"},{"key":"8089_CR28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0969-9961(03)00070-6","volume":"14","author":"PI Ho","year":"2003","unstructured":"Ho, P. I., Ashline, D., Dhitavat, S., Ortiz, D., Collins, S. C., Shea, T. B., et al. (2003). Folate deprivation induces neurodegeneration: Roles of oxidative stress and increased homocysteine. Neurobiology of Diseases, 14, 32\u201342.","journal-title":"Neurobiology of Diseases"},{"key":"8089_CR29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jnr.10416","volume":"70","author":"PI Ho","year":"2002","unstructured":"Ho, P. I., Ortiz, D., Rogers, E., & Shea, T. B. (2002). Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage. Journal of Neuroscience Research, 70, 694\u2013702.","journal-title":"Journal of Neuroscience Research"},{"key":"8089_CR30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.nbd.2006.05.009","volume":"23","author":"EL Holzbaur","year":"2006","unstructured":"Holzbaur, E. L., Howland, D. S., Weber, N., Wallace, K., She, Y., Kwak, S., et al. (2006). Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiology of Diseases, 23, 697\u2013707.","journal-title":"Neurobiology of Diseases"},{"key":"8089_CR31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1212\/WNL.38.3.459","volume":"38","author":"K Hyland","year":"1988","unstructured":"Hyland, K., Smith, I., Bottiglieri, T., Perry, J., Wendel, U., Clayton, P. T., et al. (1988). Demyelination and decreased S-adenosylmethionine in 5, 10-methylenetetrahydrofolate reductase deficiency. Neurology, 38, 459\u2013462.","journal-title":"Neurology"},{"key":"8089_CR32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.expneurol.2008.07.017","volume":"213","author":"H Ito","year":"2008","unstructured":"Ito, H., Wate, R., Zhang, J., Ohnishi, S., Kaneko, S., Ito, H., et al. (2008). Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice. Experimental Neurology, 213, 448\u2013455.","journal-title":"Experimental Neurology"},{"key":"8089_CR33","first-page":"1141","volume":"59","author":"Y Izumi","year":"2007","unstructured":"Izumi, Y., & Kaji, R. (2007). Clinical trials of ultra-high-dose methylcobalamin in ALS. Brain Nerve, 59, 1141\u20131147.","journal-title":"Brain Nerve"},{"key":"8089_CR34","doi-asserted-by":"crossref","first-page":"12571","DOI":"10.1073\/pnas.220417997","volume":"97","author":"JA Johnston","year":"2000","unstructured":"Johnston, J. A., Dalton, M. J., Gurney, M. E., & Kopito, R. R. (2000). Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 97, 12571\u201312576.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"8089_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6603(08)60823-5","volume":"61","author":"JP Julien","year":"1998","unstructured":"Julien, J. P., & Mushynski, W. E. (1998). Neurofilaments in health and disease. Progress in Nucleic Acid Research and Molecular Biology, 61, 1\u201323.","journal-title":"Progress in Nucleic Acid Research and Molecular Biology"},{"key":"8089_CR36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(01)01784-0","volume":"304","author":"C Jung","year":"2001","unstructured":"Jung, C., Rong, Y., Doctrow, S., Baudry, M., Malfroy, B., & Xu, Z. (2001). Synthetic superoxide dismutase\/catalase mimetics reduce oxidative stress and prolong survival in a mouse amyotrophic lateral sclerosis model. Neuroscience Letters, 304, 157\u2013160.","journal-title":"Neuroscience Letters"},{"key":"8089_CR37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00702-003-0096-5","volume":"111","author":"BP Kennedy","year":"2004","unstructured":"Kennedy, B. P., Bottiglieri, T., Arning, E., Ziegler, M. G., Hansen, L. A., & Masliah, E. (2004). Elevated S-adenosylhomocysteine in Alzheimer brain: Influence on methyltransferases and cognitive function. Journal of neural transmission, 111, 547\u2013567.","journal-title":"Journal of neural transmission"},{"key":"8089_CR38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1098-1136(199912)28:3<215::AID-GLIA5>3.0.CO;2-C","volume":"28","author":"JB Levine","year":"1999","unstructured":"Levine, J. B., Kong, J., Nadler, M., & Xu, Z. (1999). Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS). Glia, 28, 215\u2013224.","journal-title":"Glia"},{"key":"8089_CR39","doi-asserted-by":"crossref","first-page":"1148S","DOI":"10.1093\/ajcn\/76.5.1148S","volume":"76","author":"CS Lieber","year":"2002","unstructured":"Lieber, C. S., & Packer, L. (2002). S-Adenosylmethionine: molecular, biological, and clinical aspects\u2013an introduction. American Journal of Clinical Nutrition, 76, 1148S\u20131150S.","journal-title":"American Journal of Clinical Nutrition"},{"key":"8089_CR40","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.0022-3042.2001.00720.x","volume":"80","author":"R Liu","year":"2002","unstructured":"Liu, R., Li, B., Flanagan, S. W., Oberley, L. W., Gozal, D., & Qiu, M. (2002). Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival. Journal of Neurochemistry, 80, 488\u2013500.","journal-title":"Journal of Neurochemistry"},{"key":"8089_CR41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1357-2725(99)00139-9","volume":"32","author":"SC Lu","year":"2000","unstructured":"Lu, S. C. (2000). S-Adenosylmethionine. International Journal of Biochemistry and Cell Biology, 32, 391\u2013395.","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"8089_CR42","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/mus.20542","volume":"33","author":"DJ Mahoney","year":"2006","unstructured":"Mahoney, D. J., Kaczor, J. J., Bourgeois, J., Yasuda, N., & Tarnopolsky, M. A. (2006). Oxidative stress and antioxidant enzyme upregulation in SOD1\u2013G93A mouse skeletal muscle. Muscle and Nerve, 33, 809\u2013816.","journal-title":"Muscle and Nerve"},{"key":"8089_CR43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","volume":"26","author":"MP Mattson","year":"2003","unstructured":"Mattson, M. P., & Shea, T. B. (2003). Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends in Neurosciences, 26, 137\u2013146.","journal-title":"Trends in Neurosciences"},{"key":"8089_CR44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0304-3940(01)01972-3","volume":"308","author":"T Muller","year":"2001","unstructured":"Muller, T., Woitalla, D., Hauptmann, B., Fowler, B., & Kuhn, W. (2001). Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson\u2019s disease. Neuroscience Letters, 308, 54\u201356.","journal-title":"Neuroscience Letters"},{"key":"8089_CR45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jnutbio.2004.08.004","volume":"16","author":"AM Oommen","year":"2005","unstructured":"Oommen, A. M., Griffin, J. B., Sarath, G., & Zempleni, J. (2005). Roles for nutrients in epigenetic events. The Journal of Nutritional Biochemistry, 16, 74\u201377.","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"8089_CR46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neulet.2006.11.058","volume":"413","author":"JH Park","year":"2007","unstructured":"Park, J. H., Hong, Y. H., Kim, H. J., Kim, S. M., Kim, M. J., Park, K. S., et al. (2007). Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model. Neuroscience Letters, 413, 265\u2013269.","journal-title":"Neuroscience Letters"},{"key":"8089_CR47","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","volume":"4","author":"M Perluigi","year":"2005","unstructured":"Perluigi, M., Poon, H. F., Maragos, W., Pierce, W. M., Klein, J. B., Calabrese, V., et al. (2005). Proteomic analysis of protein expression and oxidative modification in r6\/2 transgenic mice: A model of Huntington disease. Mol Cell Proteomics, 4, 1849\u20131861.","journal-title":"Mol Cell Proteomics"},{"key":"8089_CR48","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.freeradbiomed.2005.03.030","volume":"39","author":"HF Poon","year":"2005","unstructured":"Poon, H. F., Hensley, K., Thongboonkerd, V., Merchant, M. L., Lynn, B. C., Pierce, W. M., et al. (2005). Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice\u2013a model of familial amyotrophic lateral sclerosis. Free Radical Biology and Medicine, 39, 453\u2013462.","journal-title":"Free Radical Biology and Medicine"},{"key":"8089_CR49","doi-asserted-by":"crossref","first-page":"15499","DOI":"10.1074\/jbc.M313295200","volume":"279","author":"R Rakhit","year":"2004","unstructured":"Rakhit, R., Crow, J. P., Lepock, J. R., Kondejewski, L. H., Cashman, N. R., & Chakrabartty, A. (2004). Monomeric Cu, Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. Journal of Biological Chemistry, 279, 15499\u201315504.","journal-title":"Journal of Biological Chemistry"},{"key":"8089_CR50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tins.2003.11.001","volume":"27","author":"SD Rao","year":"2004","unstructured":"Rao, S. D., & Weiss, J. H. (2004). Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis. Trends in Neurosciences, 27, 17\u201323.","journal-title":"Trends in Neurosciences"},{"key":"8089_CR51","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/intimm\/8.7.1139","volume":"8","author":"F Ratter","year":"1996","unstructured":"Ratter, F., Germer, M., Fischbach, T., Schulze-Osthoff, K., Peter, M. E., Droge, W., et al. (1996). S-adenosylhomocysteine as a physiological modulator of Apo-1-mediated apoptosis. International Immunology, 8, 1139\u20131147.","journal-title":"International Immunology"},{"key":"8089_CR52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1533317508325094","volume":"24","author":"R Remington","year":"2009","unstructured":"Remington, R., Chan, A., Paskavitz, J., & Shea, T. B. (2009). Efficacy of a vitamin\/nutriceutical formulation for moderate-stage to later-stage Alzheimer\u2019s disease: A placebo-controlled pilot study. American Journal of Alzheimer\u2019s Disease and Other Dementias, 24, 27\u201333.","journal-title":"American Journal of Alzheimer\u2019s Disease and Other Dementias"},{"issue":"Suppl 1","key":"8089_CR53","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1007\/s004150050551","volume":"247","author":"W Robberecht","year":"2000","unstructured":"Robberecht, W. (2000). Oxidative stress in amyotrophic lateral sclerosis. Journal of Neurology, 247(Suppl 1), I1\u2013I6.","journal-title":"Journal of Neurology"},{"key":"8089_CR54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., et al. (1993). Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59\u201362.","journal-title":"Nature"},{"key":"8089_CR55","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0959-4388(96)80103-6","volume":"6","author":"JD Rothstein","year":"1996","unstructured":"Rothstein, J. D. (1996). Therapeutic horizons for amyotrophic lateral sclerosis. Current Opinion in Neurobiology, 6, 679\u2013687.","journal-title":"Current Opinion in Neurobiology"},{"key":"8089_CR56","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0006-291X(81)91224-9","volume":"98","author":"RA Schatz","year":"1981","unstructured":"Schatz, R. A., Wilens, T. E., & Sellinger, O. Z. (1981). Decreased in vivo protein and phospholipid methylation after in vivo elevation of brain S-adenosyl-homocysteine. Biochemical and Biophysical Research Communications, 98, 1097\u20131107.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"8089_CR57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/17482960701856300","volume":"9","author":"S Scott","year":"2008","unstructured":"Scott, S., Kranz, J. E., Cole, J., Lincecum, J. M., Thompson, K., Kelly, N., et al. (2008). Design, power, and interpretation of studies in the standard murine model of ALS. Amyotrophic Lateral Sclerosis, 9, 4\u201315.","journal-title":"Amyotrophic Lateral Sclerosis"},{"key":"8089_CR58","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1248\/bpb.32.382","volume":"32","author":"M Sekiya","year":"2009","unstructured":"Sekiya, M., Ichiyanagi, T., Ikeshiro, Y., & Yokozawa, T. (2009). The Chinese prescription Wen-Pi-Tang extract delays disease onset in amyotrophic lateral sclerosis model mice while attenuating the activation of glial cells in the spinal cord. Biological and Pharmaceutical Bulletin, 32, 382\u2013388.","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"8089_CR59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/ajcn\/55.1.131","volume":"55","author":"J Selhub","year":"1992","unstructured":"Selhub, J., & Miller, J. W. (1992). The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. American Journal of Clinical Nutrition, 55, 131\u2013138.","journal-title":"American Journal of Clinical Nutrition"},{"key":"8089_CR60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3233\/JAD-2008-13107","volume":"13","author":"TB Shea","year":"2008","unstructured":"Shea, T. B., & Chan, A. (2008). S-adenosyl methionine: a natural therapeutic agent effective against multiple hallmarks and risk factors associated with Alzheimer\u2019s disease. Journal of Alzheimer\u2019s Disease, 13, 67\u201370.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"8089_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(02)00412-6","volume":"108","author":"TB Shea","year":"2002","unstructured":"Shea, T. B., & Rogers, E. (2002). Folate quenches oxidative damage in brains of apolipoprotein E-deficient mice: Augmentation by vitamin E. Molecular Brain Research, 108, 1\u20136.","journal-title":"Molecular Brain Research"},{"key":"8089_CR62","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1440-1789.2001.00361.x","volume":"21","author":"N Shibata","year":"2001","unstructured":"Shibata, N. (2001). Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuropathology, 21, 82\u201392.","journal-title":"Neuropathology"},{"key":"8089_CR63","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0163-7258(03)00040-8","volume":"98","author":"MJ Strong","year":"2003","unstructured":"Strong, M. J. (2003). The basic aspects of therapeutics in amyotrophic lateral sclerosis. Pharmacology and Therapeutics, 98, 379\u2013414.","journal-title":"Pharmacology and Therapeutics"},{"key":"8089_CR64","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-2008-14306","volume":"14","author":"F Tchantchou","year":"2008","unstructured":"Tchantchou, F., Graves, M., Falcone, D., & Shea, T. B. (2008). S-adenosylmethionine mediates glutathione efficacy by increasing glutathione S-transferase activity: Implications for S-adenosyl methionine as a neuroprotective dietary supplement. Journal of Alzheimer\u2019s Disease, 14, 323\u2013328.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"8089_CR65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10284150500502561","volume":"9","author":"F Tchantchou","year":"2006","unstructured":"Tchantchou, F., Graves, M., & Shea, T. B. (2006). Expression and activity of methionine cycle genes are altered following folate and vitamin E deficiency under oxidative challenge: Modulation by apolipoprotein E-deficiency. Nutritional Neuroscience, 9, 17\u201324.","journal-title":"Nutritional Neuroscience"},{"key":"8089_CR66","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pneurobio.2008.01.001","volume":"85","author":"BJ Turner","year":"2008","unstructured":"Turner, B. J., & Talbot, K. (2008). Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Progress in Neurobiology, 85, 94\u2013134.","journal-title":"Progress in Neurobiology"},{"key":"8089_CR67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jnnp.2005.083378","volume":"78","author":"JH Veldink","year":"2007","unstructured":"Veldink, J. H., Kalmijn, S., Groeneveld, G. J., Wunderink, W., Koster, A., de Vries, J. H., et al. (2007). Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 78, 367\u2013371.","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"8089_CR68","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1111\/j.1460-9568.2005.04431.x","volume":"22","author":"R Wang","year":"2005","unstructured":"Wang, R., & Zhang, D. (2005). Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model. European Journal of Neuroscience, 22, 2376\u20132380.","journal-title":"European Journal of Neuroscience"},{"key":"8089_CR69","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1006\/nbdi.2001.0443","volume":"8","author":"M Watanabe","year":"2001","unstructured":"Watanabe, M., Dykes-Hoberg, M., Culotta, V. C., Price, D. L., Wong, P. C., & Rothstein, J. D. (2001). Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiology of Diseases, 8, 933\u2013941.","journal-title":"Neurobiology of Diseases"},{"key":"8089_CR70","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.wnr.0000073685.00308.89","volume":"14","author":"P Weydt","year":"2003","unstructured":"Weydt, P., Hong, S. Y., Kliot, M., & Moller, T. (2003). Assessing disease onset and progression in the SOD1 mouse model of ALS. NeuroReport, 14, 1051\u20131054.","journal-title":"NeuroReport"},{"key":"8089_CR71","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/14660820510030149","volume":"6","author":"P Weydt","year":"2005","unstructured":"Weydt, P., Hong, S., Witting, A., Moller, T., Stella, N., & Kliot, M. (2005). Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 6, 182\u2013184.","journal-title":"Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders"},{"key":"8089_CR72","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s11064-006-9166-z","volume":"31","author":"Z Xu","year":"2006","unstructured":"Xu, Z., Chen, S., Li, X., Luo, G., Li, L., & Le, W. (2006). Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. Neurochemical Research, 31, 1263\u20131269.","journal-title":"Neurochemical Research"},{"key":"8089_CR73","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.neuropharm.2008.02.020","volume":"54","author":"X Zhang","year":"2008","unstructured":"Zhang, X., Chen, S., Li, L., Wang, Q., & Le, W. (2008). Folic acid protects motor neurons against the increased homocysteine, inflammation and apoptosis in SOD1 G93A transgenic mice. Neuropharmacology, 54, 1112\u20131119.","journal-title":"Neuropharmacology"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-009-8089-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-009-8089-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-009-8089-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:49:06Z","timestamp":1559440146000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-009-8089-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,16]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["8089"],"URL":"https:\/\/doi.org\/10.1007\/s12017-009-8089-7","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,16]]}}}